Tyler Lahusen Selected Research

Tyler Lahusen Research Topics

Disease

11	Neoplasms (Cancer) 01/2022 - 03/2002
6	Breast Neoplasms (Breast Cancer) 01/2016 - 09/2006
1	Body Weight (Weight, Body) 01/2022
1	HIV Infections (HIV Infection) 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Genomic Instability 04/2013
1	Aneuploidy (Aneuploid) 10/2011
1	Carcinogenesis 10/2011
1	Insulin Resistance 11/2010
1	Hypoglycemia (Reactive Hypoglycemia) 11/2010
1	Premature Aging 11/2010
1	Fatty Liver 09/2010
1	Retinoblastoma (Glioblastoma, Retinal) 04/2003
1	Pain (Aches) 02/2003
1	Fever (Fevers) 02/2003
1	Fatigue 02/2003
1	Carcinoma (Carcinomatosis) 11/2002
1	Squamous Cell Carcinoma of Head and Neck 11/2002
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2002

Drug/Important Bio-Agent (IBA)

4	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 07/2011 - 09/2006
3	Cyclin-Dependent Kinases (cdk Proteins)IBA 04/2003 - 03/2002
2	Proteins (Proteins, Gene)FDA Link 07/2009 - 02/2003
2	Steroid Receptors (Steroid Receptor)IBA 08/2007 - 09/2006
1	Interleukin-2 (IL2)IBA 01/2022
1	Small Interfering RNA (siRNA)IBA 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	CytokinesIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	GeranyltranstransferaseIBA 01/2022
1	AntibodiesIBA 01/2018
1	Immune Checkpoint InhibitorsIBA 01/2018
1	AntigensIBA 01/2018
1	UbiquitinIBA 01/2016
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2016
1	Glutamine (L-Glutamine)FDA Link 04/2013
1	Sirtuin 2IBA 10/2011
1	SirtuinsIBA 10/2011
1	Blood Glucose (Blood Sugar)IBA 11/2010
1	Glucose (Dextrose)FDA LinkGeneric 11/2010
1	Insulin (Novolin)FDA Link 11/2010
1	DNA (Deoxyribonucleic Acid)IBA 11/2010
1	Triglycerides (Triacylglycerol)IBA 09/2010
1	Epidermal Growth Factor (EGF)IBA 07/2009
1	Hormones (Hormone)IBA 07/2009
1	Neuregulin-1 (Neuregulin 1)IBA 07/2009
1	ErbB Receptors (EGF Receptor)IBA 08/2007
1	Tyrosine (L-Tyrosine)FDA Link 08/2007
1	SteroidsIBA 09/2006
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 02/2003
1	alvocidib (flavopiridol)IBA 02/2003
1	Biomarkers (Surrogate Marker)IBA 11/2002
1	Cyclin D3IBA 11/2002
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 11/2002
1	7-hydroxystaurosporine (UCN 01)IBA 11/2002
1	Protein Kinase CIBA 11/2002
1	Cyclin-Dependent Kinase Inhibitor p27IBA 11/2002
1	perifosineIBA 03/2002
1	Antineoplastic Agents (Antineoplastics)IBA 03/2002

Therapy/Procedure

4	Therapeutics 01/2022 - 07/2009
2	Immunotherapy 01/2022 - 01/2018
1	Intraperitoneal Injections 01/2022